Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer

NCT01599832 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT01599832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01599832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2012
Completion date
December 31, 2015
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma, recurrent renal cell cancer, stage iv renal cell cancer